Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study
Frontiers in Endocrinology · 22.05.2026 · 17
DOI: 10.3389/fendo.2026.1700331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, online erschienen am 22.05.2026. Verfasst von Lingling Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Berberine, Polycystic Ovary Syndrome, Inflammation, Hormones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Polycystic ovary syndrome (PCOS) is often associated with androgen excess, insulin resistance, and low-grade inflammation. While progesterone is standard for regulating menstrual cycles, additional therapies are often needed to address metabolic and inflammatory dysfunctions. Berberine has shown insulin-sensitizing and anti-inflammatory actions that may complement standard hormonal therapy.
Objectives
This study was designed to evaluate whether adding oral berberine to luteal-phase progesterone improves anthropometric, hormonal, metabolic, and inflammatory indicators in women with PCOS compared with progesterone alone.
Methods
Women with PCOS who received either berberine plus luteal-phase progesterone or progesterone alone for 3 months were retrospectively analyzed. Clinical records were reviewed for anthropometric, hormonal, metabolic, and inflammatory outcomes, assessed at baseline and after treatment.
Results
The berberine group showed significant within-group reductions in weight, BMI, and WHR; no significant changes occurred in the controls. Crude post-treatment between-group differences in weight, BMI, and WHR were not significant, but became significant for weight and BMI after adjustment. Although the LH and LH/FSH ratio declined in both groups, the adjusted post-treatment values were significantly lower in the berberine group compared to the control group, indicating a superior effect. Total testosterone fell only in the berberine group, yielding significant crude and adjusted between-group differences. Metabolically, fasting insulin, FBS, and HOMA-IR decreased significantly in the berberine group but not in the control group, with crude and adjusted between-group differences remaining significant. Inflammatory markers (CRP, TNF-α, IL-6) declined significantly only in the berberine group. Between-group comparisons were significant in CRP, TNF-α, and IL-6 at 3 months after adjustment.
Conclusions
These preliminary findings suggest that adjunctive berberine therapy may improve anthropometric, hormonal, metabolic, and inflammatory profiles in women with PCOS. However, well-designed randomized controlled trials are required to confirm these effects and establish definitive clinical recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, China.
- Department of Obstetrics and Gynecology, Northern Jiangsu People's Hospital, Yangzhou, Jiangsu, China.
Zitieren
APA
Gao, L., Ju, Y., Zhu, Y., Xu, J., & Lu, D. (2026). Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study. Frontiers in Endocrinology, 17. https://doi.org/10.3389/fendo.2026.1700331
Vancouver
Gao L, Ju Y, Zhu Y, Xu J, Lu D. Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study. Frontiers in Endocrinology. 2026;17. doi:10.3389/fendo.2026.1700331
BibTeX
@article{Gao2026,
author = {Gao, Lingling and Ju, Yuxin and Zhu, Yuanyuan and Xu, Jianbo and Lu, Dan},
title = {Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study},
journal = {Frontiers in Endocrinology},
year = {2026},
volume = {17},
doi = {10.3389/fendo.2026.1700331}
}
EUVIMED